Document is current
Any future updates will be listed below
-
Authors
Hanley, Michael J. https://orcid.org/0000-0001-9266-2797
Zhang, Steven
Griffin, Robert https://orcid.org/0000-0002-1907-2421
Zhu, Sean Xiaochun https://orcid.org/0009-0006-7937-812X
Fram, Robert J. https://orcid.org/0000-0001-7216-3130
Lin, Jianchang
Venkatakrishnan, Karthik https://orcid.org/0000-0003-4039-9813
Gupta, Neeraj https://orcid.org/0000-0002-5500-5218
-
Funding
Funding for this research was provided by:
This study was sponsored by Takeda Development Center Americas, Inc., Lexington, Massachusetts, USA.
- License Information
-
More Information
Article History
Received: 18 March 2024
Accepted: 10 May 2024
First Online: 24 May 2024
Declarations
:
: This study was performed in line with the ethical principles that have their origin in the Declaration of Helsinki, and the ICH Harmonised Tripartite Guideline for GCP and all applicable regulations. This study and all pertinent documents were reviewed and approved by the Advarra, Inc. Institutional Review Board.
: All participants provided written informed consent prior to the initiation of any study-specific procedures.
: Michael J. Hanley is an employee of Takeda Development Center Americas, Inc. Steven Zhang is a former employee of Takeda Development Center Americas, Inc. Robert Griffin is an employee of Takeda Development Center Americas, Inc. Sean Xiaochun Zhu is an employee of Takeda Development Center Americas, Inc. and shareholder of Takeda. Robert J. Fram is an employee of Takeda Development Center Americas, Inc. and shareholder of Takeda, Pfizer, Bristol Myers Squibb, Baxter, GE Healthcare, Gilead, Johnson and Johnson, Medtronics, Teva, Zimmer Biomet, Zimvie, and Viatris. Jianchang Lin is an employee of Takeda Development Center Americas, Inc. Karthik Venkatakrishnan is a former employee of Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited. Neeraj Gupta is an employee of Takeda Development Center Americas, Inc.
